Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Alim-Louis Benabid Honored by U.S. Research Institute

Published: Friday, October 11, 2013
Last Updated: Friday, October 11, 2013
Bookmark and Share
Benabid has received the Jay Van Andel Award for Outstanding Achievement in Parkinson’s Disease Research.

CEA-Leti has announced that Prof. Alim-Louis Benabid, chairman of CLINATEC, has been honored by a second major U.S. Parkinson’s disease (PD) organization for his work in treating PD.

Benabid received the Jay Van Andel Award for Outstanding Achievement in Parkinson’s Disease Research at Van Andel Institute’s Grand Challenges in Parkinson’s Disease Symposium in September.

The award recognizes his invention of deep brain stimulation (DBS), a highly specialized method used to treat specific kinds of neurological diseases, including Parkinson’s disease.

“Dr. Benabid has made an incredible contribution to the treatment of Parkinson's disease by developing deep brain stimulation,” said Patrik Brundin, director of the Van Andel Institute’s Center for Neurodegenerative Science.

Brundin continued, “Today over 140,000 advanced Parkinson’s patients have undergone DBS treatment, which essentially changes the ‘electric connections’ in the brain, and they are able to move remarkably much better thanks to Dr. Benabid's invention.”

Benabid, who has received many honors during his career, was awarded the 2013 Robert H. Pritzker Prize for Leadership in Parkinson’s Research from the Michael J. Fox Foundation earlier this year.

“The Van Andel Institute’s research program has a powerful impact on biomedical research in cancer and Parkinson’s disease, with an emphasis on translating scientific research results into clinical applications,” Benabid said. “I am honored to receive this award, and I’m proud to highlight the CLINATEC team’s ongoing work on infrared brain stimulation to improve treatment of PD, and perhaps severe depression, Alzheimer’s disease, Tourette’s syndrome and other neurological conditions.”

Benabid helped found CLINATEC, the multidisciplinary biomedical research center created by Leti, Grenoble University Hospital, INSERM and Joseph Fourier University in 2009.

The center allows medical practitioners, researchers, biologists, and technologists to collaborate on the frontier of health care and micro- and nanoelectronics.

Using a unique biomedical and surgery platform, CLINATEC’s main objective is to accelerate and make safer the translation of technological innovation for treating patients.

Benabid has centered his scientific activity on the approach of neurosurgical pathologies, particularly brain tumors and movement disorders.

From 1989 to 2007, he was head of the Neurosurgery Department at the University Hospital of Grenoble. He currently is a professor emeritus of biophysics at Joseph Fourier University.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More Than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Leti and Diabeloop Project Aims at Developing Artificial Pancreas
Artificial pancreas will automatically deliver the appropriate dose of insulin to patients.
Saturday, July 25, 2015
Leti Announces Launch of First European Nanomedicine Characterization Laboratory
Project combines expertise of 9 partners in 8 countries to foster nanomedicine innovation and facilitate regulatory approval.
Tuesday, July 07, 2015
Eveon, Leti Mark Milestone in Fabrication of Smart Bolus-type Micro-pump
Both Companies announces the demonstration of liquid-pumping for smart drug delivery.
Friday, March 14, 2014
Leti Announces Project to Develop New Fingerprint Technology
Ultra-high resolution sensing uses vertical piezoelectric nanowire matrices to reconstruct the smallest features of human fingerprints.
Tuesday, February 18, 2014
PIEZOMAT Project Targets New Fingerprint Technology
Ultra-high resolution sensing uses vertical piezoelectric nanowire matrices to reconstruct the smallest features of human fingerprints.
Thursday, February 13, 2014
Leti Announces MEMS Research Collaboration with OMRON
Leti’s first collaboration with a Japanese MEMS producer.
Monday, December 09, 2013
CEA-Leti Signs Agreement with Qualcomm
Agreement to assess Leti’s sequential 3D technology.
Monday, December 09, 2013
CEA-Leti Announces €1 Million Funding
bpifrance (ex OSEO) awarded grant to speed preclinical development of cancer-detecting nanoparticles.
Thursday, July 04, 2013
Patrick Boisseau Elected Chairman of the ETPN
Program will focus on building a structure that speeds innovations’ time to market and patients, while keeping Europe’s nanomed IP at home.
Monday, March 25, 2013
Attolight and Leti Launch Joint-Development Program
Program to extend applications for Company’s cathodoluminescence technology.
Monday, October 29, 2012
CEA-Leti and 7 Partners to Study Ways to Improve Treatment of Inflammatory Bowel Disease
Goal is to develop nanocarrier for targeted delivery of corticosteroids and immunosuppressants.
Thursday, April 14, 2011
Scientific News
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
ASMS 2016: Targeting Mass Spectrometry Tools for the Masses
The expanding application range of MS in life sciences, food, energy, and health sciences research was highlighted at this year's ASMS meeting in San Antonio, Texas.
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
Manufactured Stem Cells to Advance Clinical Research
Clinical-grade cell line will enable development of new therapies and accelerate early-stage clinical research.
Dengue Virus Exposure May Amplify Zika Infection
Researchers at Imperial College London have found that the previous exposure to the dengue virus may increase the potency of Zika infection.
Gender Determination in Forensic Investigations
This study investigated the effectiveness of lip print analysis as a tool in gender determination.
Identifying Novel Types of Forensic Markers in Degraded DNA
Scientists have tried to verify the nucleosome protection hypothesis by discovering STRs within nucleosome core regions, using whole genome sequencing.
Proteins in Blood of Heart Disease Patients May Predict Adverse Events
Nine-protein test shown superior to conventional assessments of risk.
Higher Frequency of Huntington's Disease Mutations Discovered
University of Aberdeen study shows that the gene change that causes Huntington's disease is much more common than previously thought.
Starving Stem Cells May Enable Scientists To Build Better Blood Vessels
Researchers from the University of Illinois at Chicago College of Medicine have uncovered how changes in metabolism of human embryonic stem cells help coax them to mature into specific cell types — and may improve their function in engineered organs or tissues.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!